June 2023 will mark the 30th anniversary of the Congressional Act of 1993, that established guidelines for the inclusion of women and minorities in all NIH-funded research. WHAM is excited to recognize the anniversary of this historic Act by hosting a series of virtual (and in-person) events throughout the year, exploring what’s changed, what hasn’t, and what needs to change in the future.
Despite some advances in our understanding of certain areas of women and cancer in the last 30 years, the field still remains understudied and underfunded. Some of the cancers that affect women most often include breast, colorectal, endometrial, lung, cervical, skin and ovarian cancers. Lung cancer is the #1 cause of cancer deaths in women, more than breast, ovarian, and cervical cancers combined, and breast, lung and colorectal cancer will account for an estimated 50% of all new cancer diagnoses in women.
This WHAM Dialogue will discuss where do we stand today with one of the leading causes of death worldwide, and the direction we need to take to create change.
Join us for this roundtable dialogue, featuring:
- Yolonda Colson, MD, PhD, Chief for the Division of Thoracic Surgery, Massachusetts General Hospital and Professor of Surgery, Harvard Medical School
- Claudia Henschke, MD, PhD, Professor of Radiology, and Head, Lung and Cardiac Screening at Mount Sinai Medical Center
- Nicole LeBoeuf, MD, MPH, Vice Chair of the Department of Dermatology, Division Chief of Oncodermatology and Director of the Center for Cutaneous Oncology, Dana-Farber Brigham Cancer Center; Director of The Program in Skin Toxicities from Anticancer Therapies, Director of Cutaneous Oncology Fellowship Program, and Co-Director of the Complex Medical Dermatology Fellowship Program, Brigham and Women’s Hospital; and Associate Professor, Harvard Medical School
